HOME >> MEDICINE >> NEWS
Margin Width The Key To Control Of Ductal Carcinoma In Situ Of The Breast

USC New England Journal Of Medicine Study Urges Caution In Use Of Radiation Therapy

LOS ANGELES, May 5, 1999 - Patients with one of the most common and curable forms of breast cancer may be undergoing radiation therapy unnecessarily, according to a University of Southern California study to be published in the May 13 New England Journal of Medicine.

The study, headed by Melvin J. Silverstein, M.D., medical director of the Harold E. and Henrietta C. Lee Breast Center at the USC/Norris Comprehensive Cancer Center, examines ductal carcinoma in situ (DCIS), a noninvasive breast cancer that has been the subject of a recent heated debate over treatment. Until 1980, DCIS was a relatively uncommon disease, representing only about 1 percent of all newly diagnosed cases of breast cancer. During the past two decades - as mammography has become more widely used and technically better - the number of new cases has increased dramatically.

Today DCIS represents as much as 40 percent of new breast cancer cases diagnosed by mammography, and estimates suggest that approximately 40,000 new cases of DCIS will be diagnosed this year in the U.S. Seventy to 80 percent of these patients are eligible for breast preserving lumpectomy rather than mastectomy. But opinion is currently divided on whether radiation therapy is necessary for all DCIS patients who choose lumpectomy.

In the NEJM article, Silverstein, a surgical oncologist, and colleagues found that radiation therapy does not appear to benefit patients where the margin width - the distance between the boundary of the lesion and the edge of the excised specimen - is 10 millimeters or more.

"Wide margin width makes complete excision more likely," says Silverstein. "Since DCIS is a noninvasive cancer that does not spread (metastasize), complete excision should cure the patient. These findings will have important ramifications for thousands of women with the disease. These data suggest that radi
'"/>

Contact: Mary Ellen Stumpl or Brenda Maceo
maceo@hsc.usc.edu
323-442-2830
University of Southern California
13-May-1999


Page: 1 2 3 4

Related medicine news :

1. Hopkins Institute for Global Tobacco Control receives elite recognition from PAHO/WHO
2. Controlling hormones could reduce risk of strokes in younger people
3. Controlling pain with your brain
4. Five more African countries to benefit from Schistosomiasis Control Initiative
5. Controlled study after Dutch caf fire highlights teen mental-health problems after disasters
6. Control valve within heart cells could protect body during heart attacks
7. Grant of 20 million to establish the Schistosomiasis Control Initiative
8. Controlled crying reduces infant sleep problems
9. Controlling blood pressure early prevents heart disease in elderly
10. AAPS Workshop to Examine Chemistry and Manufacturing Controls Trials, Emerging Products
11. Revolutionary New Procedure That Creates Controlled Heart Attack Performed For First Time In Southern California At Cedars-Sinai Medical Center

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Margin Width The Key Control Ductal Carcinoma Situ The Breast

(Date:3/30/2015)... Vancouver personal injury lawyer firm, Jiwa Law ... taken up by the firm are settled before they ... protect the interests of their clients without them having ... comes across as an achievement for the personal injury ... to their client, without compromising their rights. , ...
(Date:3/30/2015)... This report studies the global tumor ablation market ... , Based on the type of technology, the ... major segments, namely radio-frequency, microwave, cryoablation and other ... ablation) segments. Moreover, based on type of departments, ... three segments, namely, interventional radiology, surgery and oncology. ...
(Date:3/30/2015)... 30, 2015 This report studies ... over the forecast period of 2014 to 2019. ... CAGR of 6.5% from 2014 to 2019. , ... this report, the global pharmacovigilance and drug safety ... on the basis of functionality, namely, adverse event ...
(Date:3/30/2015)... 2015 On March 19th, 2015, in ... of the Detroit Lions, LiveToBeSober.org hosted the “Fighting Addiction ... ministers and bishops as well as other civic leaders ... at the luncheon, including retired Detroit Lions wide receiver ... and two survivors of their own personal battles with ...
(Date:3/30/2015)... Dr. Shahdad Arami is now ... receive $200 off their Invisalign treatment. Many people crave ... a mouthful of metal. Invisalign offers an alternative. According ... is effective for straightening teeth but has no aesthetic ... oral appearance. The Invisalign system allows both teenagers and ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2Health News:Northridge Cosmetic Dentist, Dr. Arami, is Now Offering a New Promotion on Invisalign 2
(Date:3/30/2015)... YORK , March 30, 2015 ... based nurse call systems," announced the high level ... with the ClinicAll infotainment systems. The ... on patient entertainment terminals; this allows patients to ... on their need and acuity. The advanced functionality ...
(Date:3/30/2015)... CUPERTINO, Calif. , March 30, 2015 /PRNewswire/ ... announced that it has initiated a multi-dose Phase ... DUR-928, the lead molecule in DURECT,s Epigenomic Regulator ... entity (NCE) that may have broad applicability in ... (NAFLD) and nonalcoholic steatohepatitis (NASH).  It may also ...
(Date:3/30/2015)... 30, 2015  BioPharmX Corporation (OTCQB: BPMX), a ... novel drug delivery products to address unmet needs ... the appointment of Stephen Morlock , a ... its board of directors.  Mr. Morlock,s background will ... its national roll-out of Violet iodine, the new, ...
Breaking Medicine Technology:NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3
Cached News: